NEWS FLASH
After Leaving Emory In Shame, Researcher With Ties To Drug Industry Continues To Solicit Funds From Drug Makers | Writing in Forbes today, investigator Paul Thacker details the latest ventures of Dr. Charles Nemeroff, a professor at Emory University who was forced to leave his post as chairman of psychiatry when it was revealed that he accepted hundreds of thousands of dollars in drugmaker money while conducting NIH-funded research for some of the same drugmakers. The e-mail uncovered by Thacker shows that although Nemeroff left Emory University for the University of Miami, he has continued his illicit practice of accepting larger checks from pharmaceutical corporations, even at one point bragging that his new university affiliation would protect the relationship:
“You will recall that thus far as chair of the SAB, I have received only $10,000 of the promised $40,000 due to the limitations I had during my affiliation with Emory University. You can, however, now go ahead and remunerate me for the remaining $30,000….”

Previous in TP Health


By clicking and submitting a comment I acknowledge the ThinkProgress Privacy Policy and agree to the ThinkProgress Terms of Use. I understand that my comments are also being governed by Facebook, Yahoo, AOL, or Hotmail’s Terms of Use and Privacy Policies as applicable, which can be found here.